Successful treatment of disseminated granuloma annulare with topical tacrolimus [10]

British Journal of Dermatology

Volumn 150, Issue 5, 2004, Pages 1042-1043

  Jain, S ^a   Stephens, C J M ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DAPSONE; HYDROXYCHLOROQUINE; NICOTINAMIDE; PSORALEN; RETINOID DERIVATIVE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; FEMALE; FOLLOW UP; GRANULOMA ANNULARE; HISTOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; LETTER; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRAVIOLET IRRADIATION; CASE REPORT; MIDDLE AGED; NECK;

FEMALE; GRANULOMA ANNULARE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; NECK; TACROLIMUS;

EID: 3042700159     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05947.x     Document Type: Letter

References (5)

1. Ahmed AA, Nordlind K, Schultzberg M, Liden S. Interleukin-1 alpha- and beta-, interleukin-6- and tumour necrosis factor-alpha-like immunoreactivities in chronic granulomatous skin conditions. Acta Derm Venereol (Stockh) 1994; 74: 435-40.
2. Modlin RL, Horwitz DA, Jordan RR et al. Immunopathologic demonstration of T-lymphocyte subpopulations and interleukin 2 in granuloma annulare. Pediatr Dermatol 1984; 2: 26-32.
3. Mempel M, Musette P, Flageul B et al. T-cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation. J Invest Dermatol 2002; 118: 957-66.
4. Boguniewicz M, Leung DYM. New concepts in atopic dermatitis. Compr Ther 1996; 22: 144-51.
5. Tocci MJ, Matkovich DA, Collier KA et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718-26.